Federal Circuit Rules For Apotex In Paxil Patent Suit
Glaxo had sued Canadian generic maker Apotex, the first company to challenge the validity of patents covering Paxil and the first to gain approval from the U.S. Food and Drug Administration for a generic version of the drug.
Paxil is the leading antidepressant drug on the market with annual worldwide sales totaling...
Already a subscriber? Click here to login